Basel Medical Group Ltd
BMGL
$0.60
$0.011.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.55M | 7.96M | 7.48M | 7.48M | 7.46M |
| Total Other Revenue | 26.40K | 14.70K | 3.40K | 1.70K | 0.00 |
| Total Revenue | 8.57M | 7.98M | 7.49M | 7.48M | 7.46M |
| Cost of Revenue | 6.76M | 6.03M | 5.39M | 4.88M | 4.37M |
| Gross Profit | 1.82M | 1.95M | 2.10M | 2.60M | 3.09M |
| SG&A Expenses | 106.40K | 98.30K | 90.50K | 46.70K | 2.40K |
| Depreciation & Amortization | 891.90K | 670.20K | 460.80K | 427.30K | 392.30K |
| Other Operating Expenses | 2.43M | 2.07M | 1.74M | 1.41M | 1.07M |
| Total Operating Expenses | 10.19M | 8.87M | 7.68M | 6.76M | 5.83M |
| Operating Income | -1.62M | -894.20K | -192.30K | 716.40K | 1.63M |
| Income Before Tax | -8.35M | -4.05M | 107.40K | 944.40K | 1.78M |
| Income Tax Expenses | -315.40K | -258.00K | -207.40K | 19.10K | 245.60K |
| Earnings from Continuing Operations | -8.04 | -3.79 | 0.32 | 0.93 | 1.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 400.00 | 200.00 | -- | -- | -- |
| Net Income | -8.03M | -3.79M | 315.00K | 925.50K | 1.54M |
| EBIT | -1.62M | -894.20K | -192.30K | 716.40K | 1.63M |
| EBITDA | -1.54M | -841.30K | -166.40K | 740.50K | 1.65M |
| EPS Basic | -0.38 | -0.18 | 0.02 | 0.06 | 0.09 |
| Normalized Basic EPS | -0.02 | -0.01 | 0.00 | 0.04 | 0.07 |
| EPS Diluted | -0.38 | -0.18 | 0.02 | 0.06 | 0.09 |
| Normalized Diluted EPS | -0.02 | -0.01 | 0.00 | 0.04 | 0.07 |
| Average Basic Shares Outstanding | 75.14M | 70.07M | 65.00M | 65.00M | 65.00M |
| Average Diluted Shares Outstanding | 75.14M | 70.07M | 65.00M | 65.00M | 65.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |